# Colorado University Healthcare Innovation Fund Colorado University Healthcare Innovation Fund is a Healthcare based in Boulder, CO, USA, China. ## Overview - **Organization type:** Healthcare - **Headquarters:** Boulder, CO, USA, China - **Region:** Asia - **Address:** Shanghai, China - **Founded:** 2016 - **Assets under management:** $100M+ - **Website:** https://www.cuvcfund.com - **LinkedIn:** https://www.linkedin.com/company/cu-healthcare-innovation-fund ## Regulatory record - **Reports private funds:** No ## About The fund's identity rests on a cross-continental model. It sources from university-born science in Boston — the largest NIH-funded research hub in the United States — and matches it with commercialization and clinical-partner networks in Shanghai. This two-city configuration, rather than a single headquarters, defines its investment posture. The team evaluates therapeutics, diagnostics, and devices emerging from academic medical centers in both countries, selecting candidates that can move through regulatory pathways on either side of the Pacific. Investment activity concentrates at the seed and Series A stages, with occasional participation in pre-formation company creation alongside university tech transfer offices. Sector focus spans clinical-stage biotech, medical devices, and health-IT tools that address hospital operational gaps. The fund looks for opportunities where China-based clinical trial recruitment or manufacturing partnerships can compress development timelines for US-originated science. Representative past engagements, though not broadly cataloged in public databases, have included oncology drug platforms, surgical robotics, and AI-assisted imaging diagnostics. Team and deployment figures are not publicly disclosed. No adjacent philanthropic vehicle or operating company has been publicly tied to the fund. Its limited public footprint is typical for small, thesis-driven healthcare vehicles that raise capital primarily from specialized institutional investors and family offices rather than through high-profile fund announcements. The structural differentiator is the fund's legal and operational architecture for trans-Pacific life-science translation. Unlike larger healthcare venture franchises that open satellite offices for LP relations, this fund's investment thesis relies on simultaneous in-market presence in two regulatory and reimbursement environments. The succession question and ultimate capital sources remain opaque, constrained by minimal public disclosure. ## Sectors - Healthcare Services - Digital Health - Medical Devices - Biotech ## Offices - Boston, MA, United States ## Questions ### How does the fund source its healthcare investments? Sourcing derives from the two anchor geographies: Boston's academic medical centers, including Harvard-affiliated hospitals, MIT, and the Broad Institute, and Shanghai's clinical networks and biomedical parks. The thesis hinges on identifying university spinouts in the US and matching them with development, manufacturing, or clinical partners in China, creating a bilateral deal flow that single-region funds cannot easily replicate. ### What investment stages does the fund target? The fund focuses on seed and Series A opportunities, occasionally engaging earlier through company formation alongside university technology transfer offices. The emphasis is on therapeutics, diagnostics and medical devices that have cleared initial proof-of-concept but require cross-border partnerships to advance through clinical trials or regulatory submissions in both the US and China. ### Why does the fund operate from both Shanghai and Boston? The dual-office model is intrinsic to the investment strategy, not merely an administrative convenience. Boston provides proximity to the densest academic research pipeline in the United States, while Shanghai offers access to China's scaled hospital systems, accelerated clinical trial enrollment, and lower-cost drug manufacturing infrastructure. This pairing aims to compress the timelines and costs typical of therapeutic translation. ## Related profiles - [Guild Brands](https://altss.com/profile/guild-brands) - [Sustainable Technology Ventures](https://altss.com/profile/sustainable-technology-ventures) --- Last updated: 2026-08-11T02:43:31.692Z Canonical page: https://altss.com/profile/colorado-university-healthcare-innovation-fund Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology